Drug Development
Anthropic details early drug-development work using Claude
Anthropic said it has partnered with six drug developers and advanced internal programs, with early preclinical results across oncology, allergies and muscular dystrophy.
Drug Development
Oracle Launches Life Sciences AI Platform With 129M Patient Records
Oracle unveils AI-powered data platform combining 129M+ de-identified health records with agentic AI for pharmaceutical research and drug development.
Drug Development
AI Model TxGNN Utilizes Zero-Shot Learning to Repurpose Drugs for Rare Diseases
Harvard scientists develop TxGNN, an AI model using zero-shot learning to identify new uses for existing drugs, potentially closing treatment gaps for rare diseases.